[1] |
Wang JF, Feng JG, Han J, et al. The molecular mechanisms of Tanshinone ⅡA on the apoptosis and arrest of human esophageal carcinoma cells[J]. Biomed Res Int, 2014, 2014: 582730. DOI: 10.1155/2014/582730.
|
[2] |
Chiu SC, Huang SY, Chang SF, et al. Potential therapeutic roles of tanshinone ⅡA in human bladder cancer cells[J]. Int J Mol Sci, 2014, 15(9): 15622⁃15637. DOI: 10.3390/ijms150915622.
|
[3] |
Xie J, Liu J, Liu H, et al. The antitumor effect of tanshinone ⅡA on anti⁃proliferation and decreasing VEGF/VEGFR2 on the human non⁃small cell lung cancer A549 cell line[J]. Acta Pharm Sin B, 2015, 5(6): 554⁃563. DOI: 10.1016/j.apsb.2015. 07.008.
|
[4] |
Jeon YJ, Kim JS, Hwang GH, et al. Inhibition of cytochrome P450 2J2 by tanshinone ⅡA induces apoptotic cell death in hepato⁃cellular carcinoma HepG2 cells[J]. Eur J Pharmacol, 2015, 764: 480⁃488. DOI: 10.1016/j.ejphar.2015.07.047.
|
[5] |
Zhou LH, Hu Q, Sui H, et al. Tanshinone Ⅱ: a inhibits angio⁃genesis through down regulation of COX⁃2 in human colorectal cancer[J]. Asian Pac J Cancer Prev, 2012, 13(9): 4453⁃4458.
|
[6] |
Li G, Shan C, Liu L, et al. Tanshinone ⅡA inhibits HIF⁃1α and VEGF in breast cancer cells via mTOR/p70S6K/RPS6/4E⁃BP1 signaling pathway[J]. PLoS One, 2015, 10(2): e0117440. DOI: 10.1371/journal.pone.0117440.
|
[7] |
赵雪峰, 贾楠, 李勇, 等. 丹参酮ⅡA对胃癌细胞迁移和侵袭能力的抑制作用及机制[J]. 中国癌症杂志, 2013, 23(10): 793⁃797.
|
[8] |
Sun X, Cheng G, Hao M, et al. CXCL12 /CXCR4 /CXCR7 chemokine axis and cancer progression[J]. Cancer Metastasis Rev, 2010, 29(4): 709⁃722. DOI: 10.1007/s10555⁃010⁃9256⁃x.
|
[9] |
Salazar N, Muñoz D, Kallifatidis G, et al. The chemokine receptor CXCR7 interacts with EGFR to promote breast cancer cell proliferation[J]. Mol Cancer, 2014, 13: 198. DOI: 10.1186/1476⁃4598⁃13⁃198.
|
[10] |
Shakir M, Tang D, Zeh HJ, et al. The chemokine receptors CXCR4/CXCR7 and their primary heterodimeric ligands CXCL12 and CXCL12/high mobility group box 1 in pancreatic cancer growth and development: finding flow[J]. Pancreas, 2015, 44(4): 528⁃534. DOI: 10.1097/MPA.0000000000000298.
|
[11] |
Zhang S, Hong Z, Li Q, et al. Effect of MicroRNA⁃218 on the viability, apoptosis and invasion of renal cell carcinoma cells under hypoxia by targeted downregulation of CXCR7 [J]. Biomed Pharmacother, 2016, 80: 213⁃219. DOI: 10.1016/j.biopha.2016.03.011.
|
[12] |
Pinto S, Martínez⁃Romero A, O′Connor JE, et al. Intracellular co of CXC⁃ and CC⁃ chemokine receptors and their ligands in human melanoma cell lines and dynamic variations after xenotransplantation[J]. BMC Cancer, 2014, 14: 118. DOI: 10.1186/1471⁃2407⁃14⁃118.
|
[13] |
Lee E, Han J, Kim K, et al. CXCR7 mediates SDF1⁃induced melanocyte migration[J]. Pigment Cell Melanoma Res, 2013, 26(1): 58⁃66. DOI: 10.1111/pcmr.12024.
|
[14] |
李小静, 刘排, 陈浩, 等. CXCR7在常见皮肤恶性肿瘤及其细胞株中的表达及意义[J]. 中华皮肤科杂志, 2011, 44(12): 854⁃856.
|
[15] |
刘排, 田蔚蔚, 李小静, 等. RNA 干扰趋化因子受体 CXCR7基因对黑素瘤 M14细胞侵袭和迁移的影响[J]. 中华皮肤科杂志, 2015, 48(12): 856⁃859.
|